perylene has been researched along with Retinal Neovascularization in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barliya, T; Blank, M; Grunbaum, A; Hazan, S; Lavie, G; Mandel, M; Meruelo, D; Solomon, A | 1 |
| Higuchi, A; Jo, N; Matsumura, M; Yamada, E; Yamada, H | 1 |
2 other study(ies) available for perylene and Retinal Neovascularization
| Article | Year |
|---|---|
Anti-angiogenic activities of hypericin in vivo: potential for ophthalmologic applications.
Topics: Angiogenesis Inducing Agents; Angiogenesis Inhibitors; Animals; Anthracenes; Cornea; Corneal Neovascularization; Disease Models, Animal; Endothelium, Vascular; Extracellular Signal-Regulated MAP Kinases; Fibroblast Growth Factor 2; Genes, Tumor Suppressor; Humans; Iris; Matrix Metalloproteinases, Membrane-Associated; Metalloendopeptidases; Nuclear Proteins; Perylene; Phosphorylation; Rats; Rats, Wistar; Retinal Neovascularization; Vascular Endothelial Growth Factor A | 2005 |
Hypericin inhibits pathological retinal neovascularization in a mouse model of oxygen-induced retinopathy.
Topics: Angiogenesis Inhibitors; Animals; Anthracenes; Disease Models, Animal; Enzyme Activation; Extracellular Signal-Regulated MAP Kinases; Female; Hypericum; Ischemia; Mice; Mice, Inbred C57BL; Neovascularization, Physiologic; Oxygen; Perylene; Phosphorylation; Retina; Retinal Diseases; Retinal Neovascularization | 2008 |